BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7305470)

  • 1. Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis.
    Tokunaga M; Ohuchi K; Yoshizawa S; Tsurufuji S; Rikimaru A; Wakamatsu E
    Ann Rheum Dis; 1981 Oct; 40(5):462-5. PubMed ID: 7305470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
    Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
    Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of prostaglandin E in rheumatoid synovial tissues.
    Husby G; Bankhurst AD; Williams RC
    Arthritis Rheum; 1977 Apr; 20(3):785-91. PubMed ID: 324481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flurbiprofen and phenylbutazone in rheumatoid arthritis and osteoarthrosis: a double-blind study.
    Bhasin RC; Bhuttani P; Krishnan CV; Sachdev S
    J Assoc Physicians India; 1979 May; 27(5):379-83. PubMed ID: 528489
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind crossover study to compare the efficacy of three dosage levels of flurbiprofen in the treatment of rheumatoid disease and osteoarthrosis.
    Cardoe N
    Curr Med Res Opin; 1977; 5(1):99-105. PubMed ID: 71975
    [No Abstract]   [Full Text] [Related]  

  • 6. Flurbiprofen.
    Med Lett Drugs Ther; 1989 Apr; 31(789):31-2. PubMed ID: 2648127
    [No Abstract]   [Full Text] [Related]  

  • 7. Flurbiprofen--a new anti-prostaglandin anti-inflammatory drug in rheumatoid arthritis.
    Gulati PD; Sharma RK; Sood KC; Rizvi SN
    J Assoc Physicians India; 1981 Aug; 29(8):603-7. PubMed ID: 7040332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Flurbiprofen (Flugalin) - a new non-steroidal antirheumatic agent from the propionic acid derivative series].
    Pavelka K; Susta A
    Fysiatr Revmatol Vestn; 1982 Apr; 60(2):91-9. PubMed ID: 7047336
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data.
    Lomen PL; Turner LF; Lamborn KR
    Am J Med; 1986 Mar; 80(3A):23-30. PubMed ID: 3963024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-steroid anti-inflammatory drugs and beta-endorphin].
    Di Matteo L; Evangelista L; Bosica D; Renzetti A; D'Incecco V; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):769-75. PubMed ID: 3161526
    [No Abstract]   [Full Text] [Related]  

  • 12. A long-term assessment of flurbiprofen.
    Sheldrake FE; Webber JM; Marsh BD
    Curr Med Res Opin; 1977; 5(1):106-16. PubMed ID: 71968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases].
    Egg D; Günther R; Herold M; Kerschbaumer F
    Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factor has increased reactivity with IgG from synovial fluids of patients with rheumatoid arthritis and osteoarthritis.
    Carter SD; Makh SR; Ponsford FM; Elson CJ
    Br J Rheumatol; 1989 Jun; 28(3):233-8. PubMed ID: 2730985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis.
    Trang LE; Granström E; Lövgren O
    Scand J Rheumatol; 1977; 6(3):151-4. PubMed ID: 929121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin production in arthritis.
    Sturge RA; Yates DB; Gordon D; Franco M; Paul W; Bray A; Morley J
    Ann Rheum Dis; 1978 Aug; 37(4):315-20. PubMed ID: 686864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open study of flurbiprofen in the treatment of osteoarthritis of the knee.
    Bassiouni M
    Br J Clin Pract; 1985 Oct; 39(10):393-4. PubMed ID: 4074627
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentration of interleukin-1 beta in serum and synovial fluid in patients with rheumatoid arthritis and those with osteoarthritis.
    Mannami K; Mitsuhashi T; Takeshita H; Okada K; Kuzuhara A; Yamashita F; Sakakida K
    Nihon Seikeigeka Gakkai Zasshi; 1989 Nov; 63(11):1343-52. PubMed ID: 2614163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.